Skip to main content

Leg Ulcers

0
Pipeline Programs
2
Companies
6
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Coloplast
ColoplastAustralia - Mulgrave
4 programs
BiatainN/A1 trial
Biatain AgN/A1 trial
Biatain IbuN/A1 trial
PhysiotullePHASE_41 trial
Active Trials
NCT00627094Completed120Est. Apr 2009
NCT00807664Completed182Est. Apr 2010
NCT00628004Completed93Est. Feb 2010
+1 more trials
ConvaTec
ConvaTecNJ - Bridgewater
2 programs
Compression DevicePHASE_21 trial
Aquacel® AgPHASE_31 trial
Active Trials
NCT00821431Completed90Est. Jun 2008
NCT01427491Completed18Est. Jan 2012

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
ColoplastPhysiotulle
ConvaTecAquacel® Ag
ConvaTecCompression Device
ColoplastBiatain Ag
ColoplastBiatain Ibu
ColoplastBiatain

Clinical Trials (6)

Total enrollment: 691 patients across 6 trials

NCT01238419ColoplastPhysiotulle

Physiotulle vs Urgotul in the Treatment of Leg Ulcer

Start: Nov 2009Est. completion: May 2011188 patients
Phase 4Completed
NCT01427491ConvaTecAquacel® Ag

Compare Aquacel® Ag Versus Mepilex® Border Ag to Manage Bioburden in Leg Ulcers

Start: Aug 2011Est. completion: Jan 201218 patients
Phase 3Completed
NCT00821431ConvaTecCompression Device

Compression Device Versus 4-layer Compression System

Start: May 2006Est. completion: Jun 200890 patients
Phase 2Completed
NCT00807664ColoplastBiatain Ag

Biatain Ag vs Biatain in the Treament of Leg Ulcers

Start: Dec 2008Est. completion: Apr 2010182 patients
N/ACompleted
NCT00628004ColoplastBiatain Ibu

Safety Evaluation of Biatain Ibu in Painful Chronic Venous Leg Ulcers

Start: May 2008Est. completion: Feb 201093 patients
N/ACompleted
NCT00627094ColoplastBiatain

Biatain Ibu vs. Biatain in Painful Chronic Venous Leg Ulcers

Start: Mar 2008Est. completion: Apr 2009120 patients
N/ACompleted

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

2 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.